WG Biotech ApS - 28 May 2021 Form 4 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Role
10%+ Owner
Signature
/s/ Johan Wedell-Wedellsborg
Issuer symbol
YMAB
Transactions as of
28 May 2021
Net transactions value
-$1,152,648
Form type
4
Filing time
02 Jun 2021, 16:31:34 UTC
Next filing
07 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YMAB Common Stock Sale $908,475 -25,000 -0.56% $36.34* 4,453,465 28 May 2021 Direct F1
transaction YMAB Common Stock Sale $244,173 -6,864 -0.15% $35.57* 4,446,601 01 Jun 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $35.69 to $37.29. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This transaction was executed in multiple trades at prices ranging from $35.50 to $35.96. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.